Montgomery, Ala.—A Celebrex lawsuit has been set for trial in the Circuit Court of Barbour County on June 6, 2006, for a woman who suffered a stroke at age 53, allegedly caused by taking the pain relieving drug, Celebrex.
It will most likely be the first Celebrex case to be tried in the country.
Rosie Ware took Celebrex (Celecoxib), a pharmaceutical treatment for joint pain associated with osteoarthritis and other pain-related conditions. She suffered a stroke in February 2005, and contends it was due to her use of Celebrex. Ms. Ware says she suffered physical setbacks which cost her substantial sums of money for medical, hospital and related care.
The lawsuit accuses Pfizer, Inc., Monsanto Company, Pharmacia, and G.D. Searle LLC (a subsidiary of Pharmacia) of failing to warn the medical, pharmaceutical, and scientific communities, and consumers, including Ms. Ware, and understating the potential risks and serious side effects associated with the use of Celebrex.
In a press release from the law firm, attorney Jere Beasley had the following comments:
The pharmaceutical industry and Federal Drug Administration have let the American consumer down by manufacturing and quickly approving prescription drugs that cause more harm than good. How many people need to be at risk or possibly die by taking drugs like Celebrex and Vioxx before industry standards improve?
Pfizer has no comment on the case, but Pfizer spokesman Paul Fitzhenry told the Chicago Tribune,”Celebrex continues to be available as an important treatment option for patients. The FDA and other health authorities have concluded that the benefits of Celebrex continue to outweigh its risks, and as a result, Celebrex is the only Cox-2 inhibitor remaining on the market today.”
Pfizer says worldwide annual Celebrex sales in 2006 should surpass $2 billion, however, another study released in New Zealand this week alleges people who take Celebrex are at nearly twice the risk for heart attacks as those people who use other treatments for arthritis.